This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Reprints and Permissions Copyright Information Books from ASM Press MicrobeWorld Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Matlashewski, G J Articles by Crawford, L V Search for Related Content PubMed PubMed Citation Articles by Matlashewski, G J Articles by Crawford, L V

 Previous Article

Mol Cell Biol. 1987 February; 7(2): 961-963

Primary structure polymorphism at amino acid residue 72 of human p53.

ABSTRACT

We analyzed p53 cDNA and genomic clones from a variety of normal and transformed cells. Sequence analysis of these clones revealed that amino acid residue 72 can be an arginine, proline, or cysteine. This single codon difference results in electrophoretically distinct forms of human p53 seen in normal and transformed cells.

This article has been cited by other articles:

• Piotrowski, P., Lianeri, M., Mostowska, M., Wudarski, M., Chwalinska-Sadowska, H., Jagodzinski, P. (2008). Contribution of polymorphism in codon 72 of p53 gene to systemic lupus erythematosus in Poland. Lupus 17: 148-151 [Abstract]  
• Rodier, F., Campisi, J., Bhaumik, D. (2007). Two faces of p53: aging and tumor suppression. Nucleic Acids Res 35: 7475-7484 [Abstract] [Full Text]  
• Huang, S.-P., Huang, C.-Y., Wang, J.-S., Liu, C.-C., Pu, Y.-S., Yu, H.-J., Yu, C.-C., Wu, T. T., Huang, C.-H., Wu, W.-J., Chou, Y.-H., Wu, M.-T. (2007). Prognostic Significance of p53 and X-ray Repair Cross-complementing Group 1 Polymorphisms on Prostate-Specific Antigen Recurrence in Prostate Cancer Post Radical Prostatectomy. Clin. Cancer Res. 13: 6632-6638 [Abstract] [Full Text]  
• Lind, H., Ekstrom, P. O., Ryberg, D., Skaug, V., Andreassen, T., Stangeland, L., Haugen, A., Zienolddiny, S. (2007). Frequency of TP53 Mutations in Relation to Arg72Pro Genotypes in Non Small Cell Lung Cancer. Cancer Epidemiol. Biomarkers Prev. 16: 2077-2081 [Abstract] [Full Text]  
• Sanchez, E, Sabio, J M, Callejas, J L, de Ramon, E, de Haro, M, Jimenez-Alonso, J, Ortego-Centeno, N, Sanchez-Roman, J, Gonzalez-Gay, M A, Lopez-Nevot, M A, Gonzalez-Escribano, M F, Martin, J (2006). Study of a functional polymorphism in thep53 gene in systemic lupus erythematosus: lack of replication in a Spanish population. Lupus 15: 658-661 [Abstract]  
• Cai, L., Mu, L.-N., Lu, H., Lu, Q.-Y., You, N.-C. Y., Yu, S.-Z., Le, A. D., Zhao, J., Zhou, X.-F., Marshall, J., Heber, D., Zhang, Z.-F. (2006). Dietary Selenium Intake and Genetic Polymorphisms of the GSTP1 and p53 Genes on the Risk of Esophageal Squamous Cell Carcinoma.. Cancer Epidemiol. Biomarkers Prev. 15: 294-300 [Abstract] [Full Text]  
• Jain, N., Singh, V., Hedau, S., Kumar, S., Daga, M. K., Dewan, R., Murthy, N. S., Husain, S. A., Das, B. C. (2005). Infection of Human Papillomavirus Type 18 and p53 Codon 72 Polymorphism in Lung Cancer Patients From India. Chest 128: 3999-4007 [Abstract] [Full Text]  
• Lee, Y H, Rho, Y H, Choi, S J, Ji, J D, Song, G G (2005). The functional p53 codon 72 polymorphism is associated with systemic lupus erythematosus. Lupus 14: 842-845 [Abstract]  
• Kruger, S, Bier, A, Engel, C, Mangold, E, Pagenstecher, C, von Knebel Doeberitz, M, Holinski-Feder, E, Moeslein, G, Schulmann, K, Plaschke, J, Ruschoff, J, Schackert, H K, the German HNPCC Consortium, (2005). The p53 codon 72 variation is associated with the age of onset of hereditary non-polyposis colorectal cancer (HNPCC). J. Med. Genet. 42: 769-773 [Abstract] [Full Text]  
• Mandic, R., Schamberger, C. J., Muller, J. F., Geyer, M., Zhu, L., Carey, T. E., Grenman, R., Dunne, A. A., Werner, J. A. (2005). Reduced Cisplatin Sensitivity of Head and Neck Squamous Cell Carcinoma Cell Lines Correlates with Mutations Affecting the COOH-Terminal Nuclear Localization Signal of p53. Clin. Cancer Res. 11: 6845-6852 [Abstract] [Full Text]  
• Siddique, M. M., Balram, C., Fiszer-Maliszewska, L., Aggarwal, A., Tan, A., Tan, P., Soo, K. C., Sabapathy, K. (2005). Evidence for Selective Expression of the p53 Codon 72 Polymorphs: Implications in Cancer Development. Cancer Epidemiol. Biomarkers Prev. 14: 2245-2252 [Abstract] [Full Text]  
• Vikhanskaya, F., Siddique, M. M., Kei Lee, M., Broggini, M., Sabapathy, K. (2005). Evaluation of the Combined Effect of p53 Codon 72 Polymorphism and Hotspot Mutations in Response to Anticancer Drugs. Clin. Cancer Res. 11: 4348-4356 [Abstract] [Full Text]  
• Hernandez, L., Bea, S., Pinyol, M., Ott, G., Katzenberger, T., Rosenwald, A., Bosch, F., Lopez-Guillermo, A., Delabie, J., Colomer, D., Montserrat, E., Campo, E. (2005). CDK4 and MDM2 Gene Alterations Mainly Occur in Highly Proliferative and Aggressive Mantle Cell Lymphomas with Wild-type INK4a/ARF Locus. Cancer Res. 65: 2199-2206 [Abstract] [Full Text]  
• Huang, S.-P., Wu, W.-J., Chang, W.-S. W., Wu, M.-T., Chen, Y.-Y., Chen, Y.-J., Yu, C.-C., Wu, T. T., Lee, Y.-H., Huang, J.-K., Huang, C.-H. (2004). p53 Codon 72 and p21 Codon 31 Polymorphisms in Prostate Cancer. Cancer Epidemiol. Biomarkers Prev. 13: 2217-2224 [Abstract] [Full Text]  
• Scheckenbach, K., Lieven, O., Gotte, K., Bockmuhl, U., Zotz, R., Bier, H., Balz, V. (2004). p53 Codon 72 Polymorphic Variants, Loss of Allele-Specific Transcription, and Human Papilloma Virus 16 and/or 18 E6 Messenger RNA Expression in Squamous Cell Carcinomas of the Head and Neck. Cancer Epidemiol. Biomarkers Prev. 13: 1805-1809 [Abstract] [Full Text]  
• Xi, Y.-G., Ding, K.-Y., Su, X.-L., Chen, D.-F., You, W.-C., Shen, Y., Ke, Y. (2004). p53 polymorphism and p21WAF1/CIP1 haplotype in the intestinal gastric cancer and the precancerous lesions. Carcinogenesis 25: 2201-2206 [Abstract] [Full Text]  
• Ghosh, A., Stewart, D., Matlashewski, G. (2004). Regulation of Human p53 Activity and Cell Localization by Alternative Splicing. Mol. Cell. Biol. 24: 7987-7997 [Abstract] [Full Text]  
• Koushik, A., Platt, R. W., Franco, E. L. (2004). p53 Codon 72 Polymorphism and Cervical Neoplasia: A Meta-Analysis Review. Cancer Epidemiol. Biomarkers Prev. 13: 11-22 [Abstract] [Full Text]  
• Zhang, Z.-W., Laurence, N. J., Hollowood, A., Newcomb, P., Moorghen, M., Gupta, J., Feakins, R., Farthing, M. J. G., Alderson, D., Holly, J. (2004). Prognostic Value of TP53 Codon 72 Polymorphism in Advanced Gastric Adenocarcinoma. Clin. Cancer Res. 10: 131-135 [Abstract] [Full Text]  
• Matakidou, A., Eisen, T., Houlston, R.S. (2003). TP53 polymorphisms and lung cancer risk: a systematic review and meta-analysis. Mutagenesis 18: 377-385 [Abstract] [Full Text]  
• Zhang, Z.-W., Newcomb, P., Hollowood, A., Feakins, R., Moorghen, M., Storey, A., Farthing, M. J. G., Alderson, D., Holly, J. (2003). Age-associated Increase of Codon 72 Arginine p53 Frequency in Gastric Cardia and Non-Cardia Adenocarcinoma. Clin. Cancer Res. 9: 2151-2156 [Abstract] [Full Text]  
• Tan, T., Chu, G. (2002). p53 Binds and Activates the Xeroderma Pigmentosum DDB2 Gene in Humans but Not Mice. Mol. Cell. Biol. 22: 3247-3254 [Abstract] [Full Text]  
• Wu, X., Zhao, H., Amos, C. I., Shete, S., Makan, N., Hong, W. K., Kadlubar, F. F., Spitz, M. R. (2002). p53 Genotypes and Haplotypes Associated With Lung Cancer Susceptibility and Ethnicity. JNCI J Natl Cancer Inst 94: 681-690 [Abstract] [Full Text]  
• Furihata, M., Takeuchi, T., Matsumoto, M., Kurabayashi, A., Ohtsuki, Y., Terao, N., Kuwahara, M., Shuin, T. (2002). p53 Mutation Arising in Arg72 Allele in the Tumorigenesis and Development of Carcinoma of the Urinary Tract. Clin. Cancer Res. 8: 1192-1195 [Abstract] [Full Text]  
• O'Connor, D P, Kay, E W, Leader, M, Atkins, G J, Murphy, G M, Mabruk, M J E M F (2001). p53 codon 72 polymorphism and human papillomavirus associated skin cancer. J. Clin. Pathol. 54: 539-542 [Abstract] [Full Text]  
• Rezza, G., Giuliani, M., Garbuglia, A. R., Serraino, D., Cappiello, G., Migliore, G., Branca, M., Benedetto, A., Ippolito, G. (2001). Lack of Association between p53 Codon-72 Polymorphism and Squamous Intraepithelial Lesions in Women with, or at Risk for, Human Immunodeficiency Virus and/or Human Papillomavirus Infections. Cancer Epidemiol. Biomarkers Prev. 10: 565-566 [Full Text]  
• Brooks, L. A., Tidy, J. A., Gusterson, B., Hiller, L., O’Nions, J., Gasco, M., Marin, M. C., Farrell, P. J., Kaelin, W. G. Jr., Crook, T. (2000). Preferential Retention of Codon 72 Arginine p53 in Squamous Cell Carcinomas of the Vulva Occurs in Cancers Positive and Negative for Human Papillomavirus. Cancer Res. 60: 6875-6877 [Abstract] [Full Text]  
• Hashimoto, T., Tokuchi, Y., Hayashi, M., Kobayashi, Y., Nishida, K., Hayashi, S.-i., Ishikawa, Y., Nakagawa, K., Hayashi, J.-i., Tsuchiya, E. (2000). Different Subtypes of Human Lung Adenocarcinoma Caused by Different Etiological Factors : Evidence from p53 Mutational Spectra. Am. J. Pathol. 157: 2133-2141 [Abstract] [Full Text]  
• Pierce, L. M., Sivaraman, L., Chang, W., Lum, A., Donlon, T., Seifried, A., Wilkens, L. R., Lau, A. F., Le Marchand, L. (2000). Relationships of TP53 Codon 72 and HRAS1 Polymorphisms with Lung Cancer Risk in an Ethnically Diverse Population. Cancer Epidemiol. Biomarkers Prev. 9: 1199-1204 [Abstract] [Full Text]  
• Fan, R., Wu, M.-T., Miller, D., Wain, J. C., Kelsey, K. T., Wiencke, J. K., Christiani, D. C. (2000). The p53 Codon 72 Polymorphism and Lung Cancer Risk. Cancer Epidemiol. Biomarkers Prev. 9: 1037-1042 [Abstract] [Full Text]  
• Aurelio, O. N., Kong, X.-T., Gupta, S., Stanbridge, E. J. (2000). p53 Mutants Have Selective Dominant-Negative Effects on Apoptosis but Not Growth Arrest in Human Cancer Cell Lines. Mol. Cell. Biol. 20: 770-778 [Abstract] [Full Text]  
• Berggren, P., Hemminki, K., Steineck, G. (2000). p53 intron 7 polymorphisms in urinary bladder cancer patients and controls. Mutagenesis 15: 57-60 [Abstract] [Full Text]  
• Tong, D., Kucera, E., Stimpfl, M., Kolbl, H., Leodolter, S., Zeillinger, R. (2000). Detection of p53 Polymorphism at Codon 72 by PCR and Allele-specific Oligonucleotide Hybridization on Microtiter Plates. Clin. Chem. 46: 124-126 [Full Text]  
• Hashimoto, T., Tokuchi, Y., Hayashi, M., Kobayashi, Y., Nishida, K., Hayashi, S.-i., Ishikawa, Y., Tsuchiya, S., Nakagawa, K., Hayashi, J.-i., Tsuchiya, E. (1999). p53 Null Mutations Undetected by Immunohistochemical Staining Predict a Poor Outcome with Early-Stage Non-Small Cell Lung Carcinomas. Cancer Res. 59: 5572-5577 [Abstract] [Full Text]  
• Xirodimas, D. P., Lane, D. P. (1999). Molecular Evolution of the Thermosensitive PAb1620 Epitope of Human p53 by DNA Shuffling. J. Biol. Chem. 274: 28042-28049 [Abstract] [Full Text]  
• Bea, S., Ribas, M., Hernandez, J. M., Bosch, F., Pinyol, M., Hernandez, L., Garcia, J. L., Flores, T., Gonzalez, M., Lopez-Guillermo, A., Piris, M. A., Cardesa, A., Montserrat, E., Miro, R., Campo, E. (1999). Increased Number of Chromosomal Imbalances and High-Level DNA Amplifications in Mantle Cell Lymphoma Are Associated With Blastoid Variants. Blood 93: 4365-4374 [Abstract] [Full Text]  
• Thomas, M., Kalita, A., Labrecque, S., Pim, D., Banks, L., Matlashewski, G. (1999). Two Polymorphic Variants of Wild-Type p53 Differ Biochemically and Biologically. Mol. Cell. Biol. 19: 1092-1100 [Abstract] [Full Text]  
• Chu, E., Copur, S. M., Ju, J., Chen, T.-m., Khleif, S., Voeller, D. M., Mizunuma, N., Patel, M., Maley, G. F., Maley, F., Allegra, C. J. (1999). Thymidylate Synthase Protein and p53 mRNA Form an In Vivo Ribonucleoprotein Complex. Mol. Cell. Biol. 19: 1582-1594 [Abstract] [Full Text]  
• Wang, Y.-C., Chen, C.-Y., Chen, S.-K., Chang, Y.-Y., Lin, P. (1999). p53 Codon 72 Polymorphism in Taiwanese Lung Cancer Patients: Association with Lung Cancer Susceptibility and Prognosis. Clin. Cancer Res. 5: 129-134 [Abstract] [Full Text]  
• Koduru, P. R.K., Raju, K., Vadmal, V., Menezes, G., Shah, S., Susin, M., Kolitz, J., Broome, J. D. (1997). Correlation Between Mutation in P53, p53 Expression, Cytogenetics, Histologic Type, and Survival in Patients With B-Cell Non-Hodgkin's Lymphoma. Blood 90: 4078-4091 [Abstract] [Full Text]  
• Friedlander, P., Legros, Y., Soussi, T., Prives, C. (1996). Regulation of Mutant p53 Temperature-sensitive DNA Binding. J. Biol. Chem. 271: 25468-25478 [Abstract] [Full Text]  
• Chen, P., Chen, Y., Bookstein, R, Lee, W. (1990). Genetic mechanisms of tumor suppression by the human p53 gene. Science 250: 1576-1580 [Abstract]  
• Baker, S., Fearon, E., Nigro, J., Hamilton, SR, Preisinger, A., Jessup, J., vanTuinen, P, Ledbetter, D., Barker, D., Nakamura, Y, White, R, Vogelstein, B (1989). Chromosome 17 deletions and p53 gene mutations in colorectal carcinomas. Science 244: 217-221 [Abstract]  
• Wijffels, G., Eisemann, C., Riding, G., Pearson, R., Jones, A., Willadsen, P., Tellam, R. (2001). A Novel Family of Chitin-binding Proteins from Insect Type 2 Peritrophic Matrix. cDNA SEQUENCES, CHITIN BINDING ACTIVITY, AND CELLULAR LOCALIZATION. J. Biol. Chem. 276: 15527-15536 [Abstract] [Full Text]